KLK3 SNP-SNP Interactions for Prediction of Prostate Cancer Aggressiveness
Authors
Affiliations
Risk classification for prostate cancer (PCa) aggressiveness and underlying mechanisms remain inadequate. Interactions between single nucleotide polymorphisms (SNPs) may provide a solution to fill these gaps. To identify SNP-SNP interactions in the four pathways (the angiogenesis-, mitochondria-, miRNA-, and androgen metabolism-related pathways) associated with PCa aggressiveness, we tested 8587 SNPs for 20,729 cases from the PCa consortium. We identified 3 KLK3 SNPs, and 1083 (P < 3.5 × 10) and 3145 (P < 1 × 10) SNP-SNP interaction pairs significantly associated with PCa aggressiveness. These SNP pairs associated with PCa aggressiveness were more significant than each of their constituent SNP individual effects. The majority (98.6%) of the 3145 pairs involved KLK3. The 3 most common gene-gene interactions were KLK3-COL4A1:COL4A2, KLK3-CDH13, and KLK3-TGFBR3. Predictions from the SNP interaction-based polygenic risk score based on 24 SNP pairs are promising. The prevalence of PCa aggressiveness was 49.8%, 21.9%, and 7.0% for the PCa cases from our cohort with the top 1%, middle 50%, and bottom 1% risk profiles. Potential biological functions of the identified KLK3 SNP-SNP interactions were supported by gene expression and protein-protein interaction results. Our findings suggest KLK3 SNP interactions may play an important role in PCa aggressiveness.
Wanjari U, Gopalakrishnan A Mamm Genome. 2025; .
PMID: 40056207 DOI: 10.1007/s00335-025-10119-x.
Heterogeneous genetic architectures of prostate cancer susceptibility in sub-Saharan Africa.
Janivara R, Chen W, Hazra U, Baichoo S, Agalliu I, Kachambwa P Nat Genet. 2024; 56(10):2093-2103.
PMID: 39358599 DOI: 10.1038/s41588-024-01931-3.
Cluster effect for SNP-SNP interaction pairs for predicting complex traits.
Lin H, Mazumder H, Sarkar I, Huang P, Eeles R, Kote-Jarai Z Sci Rep. 2024; 14(1):18677.
PMID: 39134575 PMC: 11319716. DOI: 10.1038/s41598-024-66311-7.
Biophysical and biochemical aspects of immune cell-tumor microenvironment interactions.
Benmelech S, Le T, McKay M, Nam J, Subramaniam K, Tellez D APL Bioeng. 2024; 8(2):021502.
PMID: 38572312 PMC: 10990568. DOI: 10.1063/5.0195244.
Rebbeck T, Janivara R, Chen W, Hazra U, Baichoo S, Agalliu I Res Sq. 2023; .
PMID: 37886553 PMC: 10602179. DOI: 10.21203/rs.3.rs-3378303/v1.